KURE logo

KraneShares MSCI All China Health Care Index ETF (KURE)

$18.58

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on KURE

AUM

$83599495

P/E ratio

49.3

Dividend yield

0.9572%

Expense ratio

0.65%

Beta

0.248459

Price on KURE

Previous close

$18.68

Today's open

$18.87

Day's range

$18.55 - $18.87

52 week range

$13.13 - $21.88

Profile about KURE

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

KURE industries and sectors

Industries

Health

Top holdings in KURE

8.87%

8.13%

News on KURE

Potential Opportunity In Chinese Markets As Trade Tensions With U.S. Cool

Easing tensions between China and the U.S. may be supportive of markets. Still uncertainty amid plans for Trump to visit China in 2026.

news source

Seeking Alpha • Nov 7, 2025

news preview

China's Flow-Driven Equity Rally May Have Further Upside

Despite mounting macro headwinds at the start of the year, Chinese equities have continued to deliver positive performance. While near-term flows can provide further upside, the durability for the equity rally will hinge on policy choices ahead.

news source

Seeking Alpha • Oct 4, 2025

news preview

Should EM Investors Trim or Retain Their China Exposure?

Getting emerging market exposure is a viable option in the current market environment. That's especially so given the global de-dollarization and prospect of further rate cuts by the Federal Reserve.

news source

ETF Trends • Oct 3, 2025

news preview

Capitalize on China Healthcare Fundraising With KURE

Looking for a reason to consider adding exposure to the China healthcare sector to your portfolio? Now may actually be a very good time to do so.

news source

ETF Trends • Sep 26, 2025

news preview

APAC Equities: The Sensitivity To Oil Prices

Among APAC equity markets, Australia has a higher beta to oil prices while India, Indonesia and Thailand have lower betas. Domestic political uncertainties have been one main reason for the decoupling trend seen in Indonesia and Thailand.

news source

Seeking Alpha • Jul 29, 2025

news preview

China's Healthcare ETFs Outpace U.S. Competitors

When it comes to creating a well-diversified portfolio, healthcare stocks have traditionally offered a variety of benefits.  As an innovative sector, healthcare companies offer the potential to build long-term portfolio growth.

news source

ETF Trends • May 16, 2025

news preview

3 ETFs Thriving in April's Market Chaos—Are You Missing Out?

With markets see-sawing up and down on a daily (or even minute-by-minute) basis on hints of global tariffs updates, there's an opportunity to time an investment to win short-term gains.

news source

MarketBeat • Apr 15, 2025

news preview

Why Chinese Equities Are Outperforming Wall Street

Has the AI trade moved to China? Why Chinese chipmakers may soon change the semiconductor space.

news source

Seeking Alpha • Mar 15, 2025

news preview

A KURE for China Tariff Concerns

An escalating trade war with China elevates a number of risk factors, but also creates pockets of overlooked opportunity for those with the appetite. Advisors and investors looking for contrarian opportunities in 2025 need look no further than China's healthcare sector and the KraneShares MSCI China All Shares Healthcare 10/40 Index ETF (KURE).

news source

ETF Trends • Mar 3, 2025

news preview

Hang Seng Index: Transforming Into A Medium-Term Bearish Trend Despite Improving Services PMI From China

Sentiment remains fragile in China and Hong Kong stock market even China services activities have improved in December. Weak market breadth and a persistent bearish trend of the Chinese yuan since November has added to more woes to the Hang Seng Index.

news source

Seeking Alpha • Jan 8, 2025

news preview

¹ Disclosures

Get started with M1

Invest in KraneShares MSCI All China Health Care Index ETF

Open an M1 investment account to buy and sell KraneShares MSCI All China Health Care Index ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in KURE on M1